Table 2 Risk and protective factors for the use of antihypertensives

Risk factor’s

Legs vascular amputation

0 (0%)

9 (16.7%)

0.002

21.923

1.241-387.216

Ex-smoker

1 (1.9%)

10 (18.5%)

0.005

11.591

1.427–94.163

Type 2 Diabetes

19 (36.5%)

35 (64.8%)

0.003

3.199

1.446–7.078

Transferrin saturation > 26.75%

21 (40%)

35 (64.8%)

0.010

2.719

1.238–5.972

Male

18 (34.6%)

35 (64.8%)

0.002

1.842

1.224–2.772

Female

34 (65.4%)

19 (35.2%)

Haemodialysis as treatment

5 (9.6%)

16 (29.6%)

0.009

1.704

1.218–2.385

Protection factors

Glomerulonephritis as etiology of CKD

16 (30.7%)

5 (9.3%)

0.005

0.230

0.077–0.685

Smokin never

44 (84.6%)

31 (57.4%)

0.002

0.245

0.097–0.619

Albumin > 4.214 gr/dL

31 (59.6%)

19 (35.2%)

0.010

0.368

0.167–0.808

Effective QB > 423.5 ml/min

32 (61.5%)

21 (38.9%)

0.016

0.398

0.182–0.869

IDWG > 4.925%

32 (61.5%)

22 (40.7%)

0.026

0.430

0.197–0.936

Hemodiafiltration as treatment

47 (90.4%)

38 (70.4%)

0.009

0.431

0.196–0.947

Urea < 103.78 mg/dL

31 (59.6%)

21 (38.9%)

0.026

0.661

0.446–0.979

Glucose < 109.27 mg/dl

31 (59.6%)

19 (35.2%)

0.012

0.608

0.404–0.914

Nonsignificant factors

Current-smoker

1 (1.9%)

0 (0%)

0.491

0.339

0.014–8.529

Hypertension as etiology of CKD

8 (15.4%)

6 (11.1%)

0.359

0.688

0.221–2.138

Polycystic Kidney disease

3 (5.8%)

2 (3.7%)

0.482

0.628

0.101–3.921

CKD of unknown etiology.

8 (15.4%)

7 (13.0%)

0.468

0.819

0.274–2.447

Access fistula

40 (76.9%)

39 (72.2%)

0.370

0.780

0.324–1.877

Access graft

4 (7.7%)

1 (1.91%)

0.170

0.226

0.024–2.097

Catheter

8 (15.4%)

14 (25.9%)

0.136

1.925

0.731–5.070

Diabetic blindness or significant retinal vascular injury

6 (11.5%)

14 (25.9%)

0.049

2.683

0.943–7.638

Cancer

1 (1.9%)

1 (1.9%)

0.743

0.962

0.059–15.798